Home › Core › ISCC-IDs › 28C68AwVTedH5

View ISCC-ID

Core Data

28C68AwVTedH5
ISCC-ID - digital asset identifier
CCbh8SZFoA13k-CTVtEY5ZCaV72-CDVgDY8YUKueV-CRjW6sLGwDamJ
ISCC-CODE - digital asset descriptor
2QTa5N4aeSrCB2MLoPdPF4AsTjstJgcLTnd
PUBLIC-KEY or WALLET-ADDRESS of DECLARING PARTY
0
Number of times updated

Seed Metadata (Immutable)

misbalance in type iii collagen formationdegradation as a novel serological biomarker for penetrating montreal b3 crohns disease

Ledger Reference

coblo
Source Ledger/Blockchain
8138
N-th ISCC Decleration on source ledger
31503a2cb72443c930fd19dd4345e64f35d9f8da65ece14e213cdb4b4066ad29
Hash of block that includes the ISCC-DECLARATION
9f6129498206153b8aceca5b0e62a0f59de53df6b94e81a1a8ec8dfbda15df6d
Hash of transaction that includes the ISCC-DECLERATION
0
Output index that includes ISCC-DECLERATION (UTXO based chains)

Mutable Metadata

[{"data": {"name": "Misbalance in type III collagen formation/degradation as a novel serological biomarker for penetrating (Montreal B3) Crohn's disease", "@type": "ScholarlyArticle", "genre": "journal-article", "author": [{"name": "W. T. van Haaften", "@type": "Person"}, {"name": "J. H. Mortensen", "@type": "Person"}, {"name": "M. A. Karsdal", "@type": "Person"}, {"name": "A. C. Bay-Jensen", "@type": "Person"}, {"name": "G. Dijkstra", "@type": "Person"}, {"name": "P. Olinga", "@type": "Person"}], "license": "cc-by-nc-nd", "@context": "http://schema.org/", "encoding": [{"@type": "MediaObject", "contentUrl": "https://www.rug.nl/research/portal/files/46982453/Haaften_et_al_2017_Alimentary_Pharmacology_amp_Therapeutics.pdf", "encodingFormat": "application/pdf"}], "publisher": {"name": "Wiley-Blackwell", "@type": "Organization"}, "identifier": [{"@type": "PropertyValue", "value": "10.1111/apt.14092", "propertyID": "DOI"}, {"@type": "PropertyValue", "value": "CCbh8SZFoA13k-CTVtEY5ZCaV72-CDVgDY8YUKueV-CRjW6sLGwDamJ", "propertyID": "ISCC"}], "datePublished": "2017-05-08"}, "schema": "schema.org", "mediatype": "application/ld+json"}]
Close